On December 18, 2021, the China Traditional Chinese Medicine Association released the 2021 TOP100 Chinese patent medicine enterprises at the information conference of the traditional Chinese medicine industry.

After being selected as the "2020 TOP100 Chinese Patent Medicine Enterprises" in 2020, Wanbangde Pharmaceutical Group was honored again on the "2021 TOP100 Chinese Patent Medicine Enterprises" list, ranking 87th.

Liu Zhanglin, vice president of the China Association of Traditional Chinese Medicine, said in his speech that the entry threshold for companies on the list reached 740 million yuan, an increase of 290 million compared with 2020. Among them, there are 10 enterprises with over 10 billion yuan, an increase of 5 over the previous year, 75 production enterprises with a value between 1 billion and 10 billion, an increase of 14 over the same period of the previous year, and 15 shortlisted enterprises with a value of less than 1 billion, an increase from the previous year. The number of enterprises with core competitiveness in the traditional Chinese medicine industry is increasing year by year.

Founded in 1970, Wanbangde Pharmaceutical Group is a high-tech enterprise specializing in the research, development, production and sales of modern Chinese medicines, chemical raw materials and preparations. Core business. The products cover cardiovascular and cerebrovascular diseases, nervous system diseases, respiratory system diseases and digestive system diseases, etc., and have the world's first Huperzine A raw material and injection, and the domestic exclusive Chinese medicine protection variety Ginkgo Leaf Dropping Pills. core product.

The company has always adhered to the road of industry-university-research integration, and has a mature technology transformation platform. R&D Center", "Provincial Enterprise Research Institute of Cardiovascular and Cerebrovascular Drugs", "Provincial Enterprise Technology Center", "The First Collaborative Innovation Alliance of Medical Research Enterprises for Pharmaceutical Products in China - Ginkgo Leaf Dropping Pill Medical Research Enterprise Collaborative Innovation Alliance", etc. , and participated in the drafting of a number of national pharmacopoeia standards. The company's registered trademark has been recognized as a well-known trademark in China.

Focus on new development and show new achievements. In the future, Wanbangde Pharmaceutical Group will continue to open up the product pattern of "featured natural botanical medicines, focusing on cardiovascular and cerebrovascular and nervous system medicines, supplemented by medicines in the respiratory system and other fields", to provide customers with high-quality products, and strive to create a A benchmarking company that "Healthy China" continues to help.